FOR IMMEDIATE RELEASE
EL SEGUNDO, CA; August 10, 2015 – Morf3D Inc, a fully integrated project-based Additive Manufacturing (AM3D) services company is thrilled to announce the appointment of Dr. Melissa Orme as our new Chief Technology Officer and Partner.
As CTO, Dr. Orme will apply her expertise in Aerospace Engineering, Materials Science and Additive Manufacturing to develop new applications for our clients. She will lead the development of Morf3D’s new R&D / Manufacturing Center located in EL SEGUNDO, CA. Her appointment is a demonstration of Morf3D’s commitment to aide in the adoption of AM3D, develop new applications, and nurture new industrial and university collaborations.
Melissa Orme, Ph.D. was born and raised in Southern California. After receiving her doctorate degree in Aerospace Engineering from the University of Southern California, she worked as a Professor at the University of California, Irvine for twelve years, where she rose to the rank of Full Professor.
As an early pioneer in the field of 3D printing, her cutting-edge research on net-form manufacturing of metallic components received international recognition and numerous awards, among which include the National Science Foundation National Young Investigator Award, The American Association of University Women: Judith Resnick Endowed Fellowship Award, the Arch T. Collwell Merit Award, and a three time recipient of the Zonta International: Amelia Earhart Fellowship Award.
She has published numerous research articles on netform manufacturing and related topics in peer-reviewed Journals and is the inventor or co-inventor of 15 United States Patents (with an additional four pending). Her patented inventions relevant to 3D printing are concerned with novel methods for net-form manufacturing with molten metal micro-droplets, novel methods of customizing the size distribution of metallic powders, and high speed direct circuit board printing.
In parallel to her academic interests she founded and managed as CEO a start-up company, Rapid Analysis & Development Co. (RA&D) with funding from MPM Corporation which was later acquired by Cookson Electronics. RA&D successfully developed her invention of direct solder pattern printing as an alternative to traditional electronics circuit printing.
In 2005 she developed a strong interest in the development of advanced medical devices for the detection of breast cancer, melanoma and osteoporosis. To this purpose she held leadership positions in two start-up companies focused on novel medical device development. The development of the novel technology for the detection of breast cancer has completed and she is currently refocusing on new applications of 3D printing.
Dr. Orme’s accomplishments are a springboard to innovation and how Morf3D intends to help solve our clients’ most complex challenges.
Please extend a warm welcome to Dr. Orme. She can be reached here by email.
For additional information please visit us at Morf3D.com
